The manuscript highlights the design of NuOrtho’s flagship arthroscopic surgical device, Ceruleau, a physiochemical scalpel, which gives surgeons an advanced option for treating damaged articular cartilage. Ceruleau has been developed in order to decrease the disease burden of osteoarthritis.
More Articles on Orthopedic Devices:
Alphatec Spine 3Q Revenue Drops 1.6%
Amedica Names Jay Moyes to Board of Directors
Globus Medical 3Q Worldwide Sales Reach $94.8M, Up 12.5%
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
